Mark Assmus

Mark Assmus

Auto-generated profile, based on publicly available information

Mark Assmus

Indiana University School of Medicine, Methodist Hospital, Department of Urology, Indianapolis, IN

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Endourology
Verified
Journal Article
Closed access
MAMark A. Assmus
Mark A. Assmus
TLTim Large
Tim Large
MLMatthew S. Lee
Matthew S. Lee
DADeepak K. Agarwal
Deepak K. Agarwal
MRMarcelino E. Rivera
Marcelino E. Rivera
AKAmy Krambeck
Amy Krambeck
Background: Holmium laser enucleation of the prostate (HoLEP) is a highly effective and durable minimally invasive surgery for benign prostatic hyperplasia. Historically, alternative treatments for large glands (≥175 cc) are associated with prolonged length of stay (LOS) and postoperative catheterization. However, advances in laser technology combined with surgical technique optimization have early evidence supporting same-day discharge. We look to examine contemporary same-day discharge outcomes for large glands. Materials and Methods: With Institutional Review Board (IRB) approval we queried our electronic medical record and retrospective clinical registry to examine perioperative outcomes of large gland (≥175 cc) prostates that underwent HoLEP with consideration for same-day discharge. Results: From December 10, 2019 to September 29, 2020 we identified 55 patients with a preoperative prostate size ≥175 cc (39 CT, 12 MRI, 4 transrectal ultrasound), of which 45 were scheduled for same-day discharge and 10 for admission. Mean preoperative prostate size was 229.9 cc (range 175–535 cc) and 36 (65.5%) were in urinary retention. Mean preoperative prostate-specific antigen (PSA) was 8.58 ng/mL, American Urological Association Symptom Score (AUASS) 22.3, and Qmax 8.8 mL/second. At 3 months postoperative follow-up mean AUASS was 6.7, PSA 0.87 ng/mL and Qmax 20.4 mL/second. All comer same-day discharge rate was 70% (38/55). Of patients planned for same-day discharge 38/45 (84%) were effective. Average LOS for all patients was 11.8 hours with catheterization of 21.2 hours. When compared with 2010 published large gland outcomes, our current LOS represents a 220% reduction. Looking specifically at patients planned for same-day discharge, average LOS and catheter duration was 8.8 and 17.0 hours, whereas LOS and catheter duration for patients planned for admission was 25.7 and 39.4 hours, respectively. Conclusions: We report the first outcomes of preoperatively planned same-day discharge for HoLEP in large glands (≥175 cc). A combination of technologic advances and optimization of technique have allowed for a safe adoption of same-day discharge, providing additional advantages over alternative large gland treatments.

18 June 2021 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
MLMatthew S. Lee
Matthew S. Lee
MAMark Assmus
Mark Assmus
DADeepak Agarwal
Deepak Agarwal
TLTim Large
Tim Large
AKAmy Krambeck
Amy Krambeck

28 June 2021 in CEN Case Reports
Verified
Journal Article
Closed access
PDF file
AWAndre Woloshuk
Andre Woloshuk
MLMatthew Lee
Matthew Lee
MAMark Assmus
Mark Assmus
DADeepak Agarwal
Deepak Agarwal
AKAmy Krambeck
Amy Krambeck
TLTim Large
Tim Large

1 August 2021 in Urology
Verified
Journal Article
Closed access
MLMatthew S. Lee
Matthew S. Lee
MAMark Assmus
Mark Assmus
DADeepak Agarwal
Deepak Agarwal
MRMarcelino E. Rivera
Marcelino E. Rivera
TLTim Large
Tim Large
AKAmy Krambeck
Amy Krambeck

1 November 2021 in Urology
Verified
Journal Article
Closed access
MLMatthew S. Lee
Matthew S. Lee
MAMark Assmus
Mark Assmus
DADeepak Agarwal
Deepak Agarwal
AKAmy Krambeck
Amy Krambeck
TLTim Large
Tim Large